FDA authorises second booster of Pfizer/BioNTech Covid shot

The United States regulators authorised a second booster dose of Pfizer Inc and BioNTech SE's Covid-19 vaccine for people 50 and older due to concerns about waning immunity in the age group, the drugmakers said on Tuesday.